Breaking News Instant updates and real-time market news.

DNA

Bought by RHHBY

, BWA

BorgWarner

$50.92

-1.09 (-2.10%)

07:39
10/13/17
10/13
07:39
10/13/17
07:39

Auto suppliers supported by stronger Euro and rising EU output, says KeyBanc

KeyBanc analyst Brett Hoselton raised his profit targets on several auto suppliers, maintaining a positive view on the group overall heading into Q3 earnings. Hoselton says the outlook for the quarter is intact, as lower than expected production of light vehicles was in part offset by stronger EU output. He also cites FX tailwinds, with the Euro have appreciated about 7% sequentially and further supporting revenue in Q3 and possibly FY18. Hoselton raised his profit targets on Delphi Automotive (DLPH) to $106 from $100, Magna International (MGA) to $59 from $55, Lear Corp (LEA) to $184 from $180, and BorgWarner (BWA) to $56 from $50, maintaining an Overweight rating on all these stocks. The analyst is especially bullish on Dana Inc (DNA) given the recent upward revisions to North America Class 8 production, but says his Sector Weight rating reflects the stock prices.

DNA

Bought by RHHBY

BWA

BorgWarner

$50.92

-1.09 (-2.10%)

LEA

Lear

$172.31

-1.1 (-0.63%)

MGA

Magna

$54.40

-0.41 (-0.75%)

DLPH

Delphi

$98.10

-1.15 (-1.16%)

  • 25

    Oct

  • 26

    Oct

  • 30

    Oct

  • 08

    Nov

  • 09

    Nov

DNA Bought by RHHBY

BWA BorgWarner
$50.92

-1.09 (-2.10%)

07/18/17
CHLM
07/18/17
DOWNGRADE
Target $22
CHLM
Hold
Sevcon downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Eric Stine downgraded Sevcon (SEV) to Hold from Buy, with a $22 price target, after the company announced a definitive agreement to be acquired by BorgWarner (BWA) for $22 per share in an all-cash transaction. The analyst believes that this proposed acquisition is a clear indication of the market shift to electrification and hybridization as automotive OEMs operate in a world with a greater focus on sustainability and more stringent emissions standards which cannot be met with existing technology.
07/28/17
BMOC
07/28/17
NO CHANGE
BMOC
BorgWarner price target raised to $55 from $50 at BMO Capital
BMO Capital analyst Richard Carlson raised his price target on BorgWarner as he says the company reported "strong beat and raise" results. He expects the company to continue to outperform ,driven by "tightening global emissions/ fuel economy standards and demands for increased electrification on vehicles."
08/17/17
BARD
08/17/17
NO CHANGE
BARD
Outperform
Auto suppliers are compelling and should be bought, says Baird
Baird analyst David Leiker believes the auto suppliers are compelling and should be bought. He noted the auto supplier universe reported growth of 4% organic growth and 10-15% earnings growth in a no growth global production environment during Q2, validating their attractiveness. His top ideas include Visteon (VC), Borg Warner (BWA), Adient (ADNT), and Delphi (DLPH).
10/12/17
DBAB
10/12/17
DOWNGRADE
Target $55
DBAB
Hold
BorgWarner downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Rod Lache downgraded BorgWarner (BWA) to Hold with an unchanged price target of $55. The analyst believes the shares are no longer "grossly mispriced" and sees better opportunities elsewhere in the space. Lache prefers shares of General Motors (GM), American Axle (AXL) and Magna (MGA) for automotive exposure.
LEA Lear
$172.31

-1.1 (-0.63%)

09/28/17
09/28/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Estee Lauder (EL) initiated with a Neutral at DA Davidson. 2. Ebix (EBIX) initiated with an Outperform at William Blair. 3. Lear (LEA) initiated with a Buy at Jefferies. 4. Vistra Energy (VST) initiated with a Buy at Citi. 5. MediWound (MDWD) initiated with an Outperform at Cowen. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/17
UBSW
10/03/17
DOWNGRADE
Target $182
UBSW
Neutral
Lear downgraded to Neutral from Buy at UBS
UBS analyst Colin Langan downgraded Lear to Neutral saying the E-System spin upside seems already priced in following the recent share rally. The analyst also sees limited multiple expansion and risk to 2018 seating margins. He raised his price target for Lear shares to $182 from $158 despite the downgrade on valuation.
10/03/17
10/03/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Aegion (AEGN) downgraded to Hold from Buy at Craig-Hallum with analyst Eric Stine citing valuation following the third quarter update and with restructuring a work in progress. 2. Urban Outfitters (URBN) downgraded to Sell from Hold at Deutsche Bank with analyst Tiffany Kanaga saying the valuation has "stretched to elevated levels." 3. Tile Shop (TTS) downgraded to Underperform from Market Perform at Telsey Advisory with analyst Joseph Feldman saying he is concerned the deceleration will continue for several quarters given weakness was attributed to increased competition that led to the company to increase promotions. 4. Lear (LEA) downgraded to Neutral from Buy at UBS with analyst Colin Langan saying the E-System spin upside seems already priced in following the recent share rally. 5. MGM Resorts (MGM) downgraded to Neutral from Positive at Susquehanna. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/28/17
JEFF
09/28/17
INITIATION
Target $197
JEFF
Buy
Lear initiated with a Buy at Jefferies
Jefferies analyst David Kelley started Lear Corp. with a Buy rating and $197 price target. The analyst views the company as a "solid legacy supplier play" with Seating gaining market share.
MGA Magna
$54.40

-0.41 (-0.75%)

08/28/17
MSCO
08/28/17
DOWNGRADE
Target $47
MSCO
Equal Weight
Magna downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley Adam Jonas downgraded Magna to Equal Weight and lowered its price target to $47 from $56 saying his estimates are 10%+ below consensus on cyclical pressures and lowered his long-term growth and margin outlook on concerns shares capture most of the Auto 2.0 value than previously expected.
10/12/17
DBAB
10/12/17
DOWNGRADE
Target $104
DBAB
Hold
Delphi downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Rod Lache downgraded Delphi Automotive (DLPH) to Hold and lowered his price target for the shares to $104 from $108. The analyst views the valuation as fair at current share levels and sees better opportunities elsewhere in the space. Lache prefers shares of General Motors (GM), American Axle (AXL) and Magna (MGA) for automotive exposure.
08/14/17
DBAB
08/14/17
NO CHANGE
Target $61
DBAB
Buy
Magna 'deeply undervalued' after post-earnings selloff, says Deutsche Bank
Deutsche Bank analyst Rod Lache calls Magna's Q2 results "pretty decent" despite the corresponding share weakness. The company's free cash flow generation "appears strong" and is underappreciated by investors, Lache tells investors in a post-earnings research note. He views the shares as "deeply undervalued" and upped his price target for Magna to $61 from $59. Lache keeps a Buy rating on the name.
07/26/17
EDJN
07/26/17
DOWNGRADE
EDJN
Hold
Magna downgraded to Hold from Buy at Edward Jones
DLPH Delphi
$98.10

-1.15 (-1.16%)

10/10/17
UBSW
10/10/17
DOWNGRADE
Target $102
UBSW
Neutral
Delphi downgraded to Neutral from Buy at UBS
UBS analyst Colin Langan downgraded Delphi Automotive to Neutral saying break-up upside is now priced in at current share levels. The stock has risen 28% since the news, bringing the year-to-date increase to 49%, Langan tells investors in a research note. The analyst keeps a $102 price target for the shares.
09/28/17
COWN
09/28/17
NO CHANGE
Target $120
COWN
Outperform
Delphi transitioning to tech solutions vendor, says Cowen
Cowen analyst Jeffrey Osborne attended the Delphi analyst day and came away confident in the positioning through 2022 of Aptiv, where the two key segments provide pure-play exposure to both electrification and autonomous driving. The analyst sees Delphi transitioning from a Tier-1 supplier to a tech solutions vendor. Osborne reiterated his Outperform rating and $120 price target on Delphi shares.
09/28/17
BARD
09/28/17
NO CHANGE
Target $128
BARD
Outperform
Delphi price target raised to $128 from $110 at Baird
Baird analyst David Leiker raised his price target on Delphi to $128 as he believes valuation can move higher over time as investors focus on the trajectory of new business wins and the opportunity for accelerating future revenue growth. Leiker reiterated his Outperform rating on Delphi shares.

TODAY'S FREE FLY STORIES

19:15
10/20/17
10/20
19:15
10/20/17
19:15
General news
Breaking General news story  »

Federal Reserve Chair…

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

18:59
10/20/17
10/20
18:59
10/20/17
18:59
Hot Stocks
FDA cannot approve Antares Pharma's Xyosted NDA »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

18:55
10/20/17
10/20
18:55
10/20/17
18:55
Conference/Events
Federal Reserve Chairperson delivers a lecture at NEC Dinner »

Federal Reserve…

SHIP

Seanergy Marine

$1.24

0.0199 (1.63%)

17:50
10/20/17
10/20
17:50
10/20/17
17:50
Syndicate
Breaking Syndicate news story on Seanergy Marine »

Seanergy Marine files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLI

Houlihan Lokey

$41.56

0.18 (0.43%)

17:49
10/20/17
10/20
17:49
10/20/17
17:49
Syndicate
Breaking Syndicate news story on Houlihan Lokey »

Houlihan Lokey files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GEO

Geo Group

$26.20

0.2 (0.77%)

17:48
10/20/17
10/20
17:48
10/20/17
17:48
Syndicate
Breaking Syndicate news story on Geo Group »

Geo Group files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

17:37
10/20/17
10/20
17:37
10/20/17
17:37
Hot Stocks
DBV sinks following peanut allergy trial miss, Aimmune soars »

Shares of DBV…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KALV

KalVista

$11.26

1.99 (21.47%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:24
10/20/17
10/20
17:24
10/20/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: KalVista (KALV),…

KALV

KalVista

$11.26

1.99 (21.47%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPCI

Intellipharmaceutics

17:23
10/20/17
10/20
17:23
10/20/17
17:23
Hot Stocks
Breaking Hot Stocks news story on Intellipharmaceutics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:21
10/20/17
10/20
17:21
10/20/17
17:21
Hot Stocks
DBV Technologies: PEPITES trial does not reach primary endpoint »

DBV Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.92

1.17 (2.18%)

17:08
10/20/17
10/20
17:08
10/20/17
17:08
Periodicals
Regulator criticizes Wells Fargo over deceptive auto insurance program, NYT says »

The Office of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 02

    Nov

  • 07

    Nov

  • 29

    Nov

  • 15

    Jan

ALIM

Alimera Sciences

17:01
10/20/17
10/20
17:01
10/20/17
17:01
Syndicate
Alimera Sciences to sell $25M in shares in an 'at the market offering' »

On October 20, Alimera…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYMC

Symantec

$32.66

0.33 (1.02%)

16:51
10/20/17
10/20
16:51
10/20/17
16:51
Syndicate
Breaking Syndicate news story on Symantec »

Symantec files to sell 1M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

EBMT

Eagle Bancorp

$19.55

0.15 (0.77%)

16:44
10/20/17
10/20
16:44
10/20/17
16:44
Hot Stocks
Breaking Hot Stocks news story on Eagle Bancorp »

EJF Capital reports 7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALV

KalVista

$11.26

1.99 (21.47%)

16:43
10/20/17
10/20
16:43
10/20/17
16:43
Hot Stocks
Breaking Hot Stocks news story on KalVista »

Longwood Fund II reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAGX

Jaguar Health

$0.19

0.002 (1.08%)

16:41
10/20/17
10/20
16:41
10/20/17
16:41
Syndicate
Breaking Syndicate news story on Jaguar Health »

Jaguar Health files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$345.10

-6.71 (-1.91%)

16:40
10/20/17
10/20
16:40
10/20/17
16:40
Hot Stocks
Tesla amends 'warehouse agreements' to increase commitments to $1.1B »

On October 18,Tesla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

SNV

Synovus

$47.30

0.54 (1.15%)

16:38
10/20/17
10/20
16:38
10/20/17
16:38
Hot Stocks
Synovus CBO sells 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

  • 15

    Nov

GTXI

GTx

$7.92

0.1 (1.28%)

16:38
10/20/17
10/20
16:38
10/20/17
16:38
Syndicate
Breaking Syndicate news story on GTx »

GTx files to sell 8.77M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASB

Associated Banc-Corp

$25.90

1.3 (5.28%)

, BKMU

BankMutual

$10.80

0.55 (5.37%)

16:36
10/20/17
10/20
16:36
10/20/17
16:36
Conference/Events
BankMutual to host special shareholder meeting »

Special Shareholder…

ASB

Associated Banc-Corp

$25.90

1.3 (5.28%)

BKMU

BankMutual

$10.80

0.55 (5.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

CNXR

Connecture

$0.49

-0.01 (-2.00%)

16:35
10/20/17
10/20
16:35
10/20/17
16:35
Hot Stocks
Breaking Hot Stocks news story on Connecture »

Connecture trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$23.83

0.25 (1.06%)

, PG

Procter & Gamble

$88.25

-3.34 (-3.65%)

16:31
10/20/17
10/20
16:31
10/20/17
16:31
General news
On The Fly: Top stock stories for Friday »

Stocks opened sharply…

GE

General Electric

$23.83

0.25 (1.06%)

PG

Procter & Gamble

$88.25

-3.34 (-3.65%)

CELG

Celgene

$121.33

-14.63 (-10.76%)

SNCR

Synchronoss

$11.39

-0.12 (-1.04%)

IL

Bought by SNCR

SKX

Skechers

$33.99

9.96 (41.45%)

PYPL

PayPal

$70.97

3.72 (5.53%)

NCR

NCR Corp.

$33.05

-4 (-10.80%)

LHO

LaSalle Hotel

$28.52

-1.94 (-6.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 29

    Nov

  • 30

    Nov

16:30
10/20/17
10/20
16:30
10/20/17
16:30
Options
Preliminary option volume of 22.9M today »

Preliminary option volume…

MKL

Markel

$1,078.23

14.88 (1.40%)

, SNC

State National

$21.05

0.02 (0.10%)

16:26
10/20/17
10/20
16:26
10/20/17
16:26
Conference/Events
State National to host special shareholder meeting »

Special Shareholder…

MKL

Markel

$1,078.23

14.88 (1.40%)

SNC

State National

$21.05

0.02 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

RYTM

Rhythm Pharmaceuticals

$23.08

-0.17 (-0.73%)

16:22
10/20/17
10/20
16:22
10/20/17
16:22
Hot Stocks
Breaking Hot Stocks news story on Rhythm Pharmaceuticals »

Orbimed Advisors reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.